ECM
AMPE

ExodusPoint Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

ExodusPoint Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,612
Closed -$817K – 3003
2021
Q1 		$817K Buy
1,612
+1,264
+363% +$652K 0.01% 1042
2020
Q4 		$166K Buy
+348
New +$114K ﹤0.01% 1772

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

ExodusPoint Capital Management's AMPE Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2021, closing a stake of 1,612 shares — an estimated $817K sold.

ExodusPoint Capital Management first reported a position in AMPE in Q4 2020 and held it in 2 quarters. The position peaked at $817K in Q1 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q2 2021.

  • ExodusPoint Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 1,612 Ampio Pharmaceuticals Inc. shares in Q2 2021, an estimated $817K.
  • ExodusPoint Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 2 quarters.
  • ExodusPoint Capital Management's Ampio Pharmaceuticals Inc. position peaked at $817K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.